Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07438938

Measurement of Airway Opening Index During Out-of-hospital Cardiac Arrest: The Lazarus AOI Trial.

Out-of-hospital cardiac arrest (OHCA) is a leading cause of death worldwide. Despite constantly improving resuscitation techniques, the chances of survival remain limited. During cardiopulmonary resuscitation (CPR), a closure of the airway may occur, impeding ventilation. This phenomenon also complicates the interpretation of the end-tidal CO2 (ETCO2) in the capnogram. The extent to which airway closure occurs is quantified by the Airway Opening Index (AOI). This can be calculated from the capnogram and is seen as a measure of the quality of CPR applied as well as a possible indicator to predict the outcome of CPR.

In this study, we analyse capnogram data from approximately 150 cases, collected during interventions for OHCA and logged in the Lazarus database (UZ Gent and AZORG) to answer three research questions below:

1. What is the prevalence of AOI during CPR? 2. Is there a correlation between AOI and return of spontaneous circulation (ROSC)? 3. Does the application of positive end-expiratory pressure (PEEP) affect the AOI and ROSC?

A mathematical model for calculating AOI, based on a method from previous work by Bandhari et al. [1] will be developed. Using this model, the AOI will be calculated from the individual capnograms for all cases in the Lazarus database.

In addition, a multivariable regression model will be used to analyse whether AOI can be used to predict ROSC. Corrections will be made for relevant confounders such as age, gender, witnessed arrest and rhythm pattern.

Finally, it is investigated whether PEEP has a positive influence on AOI. This study aims to contribute to better insights into airway dynamics during CPR and the optimization of ventilation in OHCA.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ghent University Hospital

Ghent, East-Flanders, B9000, Belgium

Location status: Recruiting

Location contact

Said Hachimi Idrissi, MD, PhD

CONTACT

[email protected]

0032 9 332 50 24

About this study

This study is a retrospective observational cohort study based on capnography data from out-of-hospital cardiac arrest cases registered in the Lazarus database.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult (over 18 years old) patients with out-of-hospital cardiac arrest.
  • Patients undergoing cardiopulmonary resuscitation (CPR).
  • Patients who were intubated and had available capnogram recordings immediately after intubation.

Exclusion criteria

  • Patients that were not intubated
  • Patients that did not receive CPR following intubation
  • Cases with a technical challenge with the ETCO₂ measurement (i.e., issues with waveform data of the capnogram.

Treatment and study plan

Primary outcomes

  1. ROSC

    Time frame: Initial resuscitation (first day)

    Return-of-spontaneous circulation during initial resuscitation.

Study contacts

Contact information is provided by the study sponsor or research team.

Said Hachimi Idrissi, MD, PhD

CONTACT

[email protected]

0032 9 332 50 24

Thomas Tackaert, MD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Registry information

Acronym: Lazarus-AOI

Important dates

Study start
2022
Primary completion
2026
Study completion
2027
First posted
Feb 27, 2026
Registry last updated
Feb 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.